Karyopharm Therapeutics | Laba Kotor Pada Penjualan



Gross Profit On Sales Perubahan Tanggal
AbbVie USD 10.71B 458M 2024-12
Abbott USD 5.92B 114M 2025-03
Amgen USD 5.54B 430M 2025-03
AstraZeneca USD 11.35B 819M 2025-03
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Eli Lilly USD 10.5B 624.7M 2025-03
GlaxoSmithKline GBP 5.59B 34M 2025-03
Incyte USD 985.09M 111.22M 2025-03
J&J USD 14.6B 816M 2025-03
MacroGenics USD 13.86M 94.98M 2024-12
Merck USD 12.77B 849M 2025-03
Novartis USD 10.23B 294M 2024-12
Novartis USD 10.24B 313M 2024-12
Pfizer USD 11.12B 987M 2025-03
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Takeda JPY 671.32B 55.93B 2025-03
TG Therapeutics USD 92.79M 18.25M 2024-12
Ultragenyx Pharmaceutical USD 110.63M 37.35M 2025-03
Xencor -45143000 40.69M 2024-09



Karyopharm Therapeutics Laba Kotor Pada Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Jul 2025.